200,000 doses of Novavax JN. 1 COVID-19 vaccine available from Jan. 1

Taipei, Dec. 27 (CNA) The Taiwan Centers for Disease Control (CDC) on Friday announced that it will make 200,000 doses of protein-based vaccine targeting the JN. 1 subvariant of COVID-19 available to the general public from Jan. 1.